Internal Server Error

List of Pfizer's Acquisitions

lockFilter this list
Pfizer has made a total of 41 acquisitions. The firm’s peak activity occurred in 2008 and 2007, with 4 acquisitions each, and in 2022, with 3 acquisitions. Its investment activity spans 23 sectors, including Oncology, Diversified Pharmaceuticals, and Infectious Diseases, across 5 countries, notably the United States, United Kingdom, and Canada. The average number of acquisitions per year from 2020 to 2025 is 1.6, with 0 acquisitions completed in the current calendar year. In September 2025, the firm completed its most recent acquisition of Metsera, a New York City-based biopharmaceutical company founded in 2022 that focuses on medicines for obesity and metabolic diseases.

Here's the year on year acquisition history of Pfizer:

Year on year acquisition history of Pfizer20252023202220212019Acquisitions Round Date (Yearly)01234
  • Number of Total Acquisitions
Year
# Acquisitions
2025
1
2023
1
2022
3
2021
3
2019
2
2016
3
2015
2
2014
2
2012
3
2011
2
2010
3
2008
4
2007
4
2006
2
2005
3
2004
1
2003
1
2002
1

Recent acquisitions by Pfizer

Pfizer's most recent acquisition - Metsera is a Biopharmaceutical company focusing on medicines for obesity and metabolic diseases, founded in 2022 and located in New York City. Pfizer acquired it in September 2025 for a price of $*****.

Here is the list of all acquisitions by Pfizer sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Sep 22, 2025
wulc
t{gy
86
492
Mar 13, 2023
rykv
btl{
45
948
Aug 08, 2022
sfku
zhkn
35
329
May 10, 2022
aqzi
zhmf
18
663
Apr 07, 2022
dlrk
vfoq
26
103

View the full list of acquisitions

Sign Up for Free

News related to Pfizer's acquisitions

lockFilter this list

Media has covered Pfizer for a total of 217 events in the last 1 year, 36 of them have been about acquisition activity.

View More Pfizer Recent News

FAQs about Acquisitions by Pfizer

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford